Aquestive Therapeutics (AQST) Return on Assets: 2018-2024

Historic Return on Assets for Aquestive Therapeutics (AQST) over the last 7 years, with Dec 2024 value amounting to -0.56%.

  • Aquestive Therapeutics' Return on Assets fell 23.00% to -0.54% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.54%, marking a year-over-year decrease of 23.00%. This contributed to the annual value of -0.56% for FY2024, which is 42.00% down from last year.
  • As of FY2024, Aquestive Therapeutics' Return on Assets stood at -0.56%, which was down 304.22% from -0.14% recorded in FY2023.
  • Over the past 5 years, Aquestive Therapeutics' Return on Assets peaked at -0.14% during FY2023, and registered a low of -1.13% during FY2021.
  • Moreover, its 3-year median value for Return on Assets was -0.56% (2024), whereas its average is -0.54%.
  • In the last 5 years, Aquestive Therapeutics' Return on Assets spiked by 78bps in 2023 and then crashed by 42bps in 2024.
  • Aquestive Therapeutics' Return on Assets (Yearly) stood at -0.79% in 2020, then plummeted by 34bps to -1.13% in 2021, then increased by 22bps to -0.91% in 2022, then skyrocketed by 78bps to -0.14% in 2023, then crashed by 42bps to -0.56% in 2024.